Capital Biosciences
​Your Trusted Partner in Biospecimen Research

Capital Biosciences Overview

Capital Biosciences, established in 2007 and based in Washington DC, is a leading Biospecimen CRO dedicated to providing high-quality, clinically annotated biospecimens to researchers globally. With procurement sites across Eastern Europe, the Baltic countries, and the US, CBI supports life science research through a diverse biospecimen collection covering oncology, autoimmunity, cardiovascular diseases, and more.

Mission and Commitment

CBI is committed to fostering global partnerships to advance life science research for the benefit of humanity. We strive to support the discovery of new medicines and therapies, ensuring that our efforts extend and improve the quality of life.

Biospecimen Collection and Services

We offer a diverse range of biospecimens, including tissues, blood derivatives, biofluids, and isolated cells. Our services include full chain of custody specimen collection, web-based project tracking, and flexible study design capabilities to accommodate custom protocols. Our procurement sites follow consistent collection protocols, ensuring high-quality specimens that meet GCP/HIPAA standards.

Therapeutic Areas

Our collection focuses on a variety of therapeutic areas:

• Oncology and hematology-oncology (core expertise)
• Autoimmune, neurodegenerative, and metabolic disorders
• Infectious diseases (HIV, HBV, HCV, HPV)

Quality Control and Ethical Considerations

CBI ensures stringent quality control, with SOPs implemented across all sites, dual verification of processes, and comprehensive data tracking. All specimens are legally procured under USA and international laws, maintaining ethical standards. We adhere to GCP/HIPAA compliance, ensuring specimens are de-identified and suitable for research.

Ancillary Services

In addition to biospecimens, we offer ancillary services, including:

• Custom cell immortalization and stable cell line generation
• Recombinant lentivirus production
• Liquid biopsy and cfDNA extraction

Why Choose Capital Biosciences

Our experienced team, commitment to ethical standards, and advanced collection infrastructure make us a trusted partner for researchers. Our joint ventures, such as Epigene Diagnostics LLC, enhance our capabilities in biomarker discovery and diagnostics, ensuring comprehensive support for your research needs.